AstraZeneca's booth is seen during an expo in Beijing in November. The pharma company announced an investment of $2.5 billion to establish a global R&D center in Beijing. CHINA DAILY Multinational ...

In ‘Giants Awakened,’ the sixth episode of ‘House of David,’ ill omens gather on the horizon as the House of Saul faces enemies from every angle. As King Saul recedes further and further into his ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer (NSCLC), the British pharma has rolled out early data from a trial ...

Comcast has appointed David Novak, one of its board members and the former CEO of fast-food company Yum! Brands, as chairman of its soon-to-spin-off collection of cable TV networks. SpinCo ...

Speaking to the Commons business and trade select committee on Tuesday, AstraZeneca’s chairman Shaun Grady confirmed that delays in securing a £90 million government contribution led to the collapse ...

“House of David” has been renewed for a second season at Amazon Prime Video. The news comes after the series premiered with 22 million viewers in its first 17 days of streaming, and ahead of ...

Just three weeks after its Season 1 premiere, Prime Video has ordered a second season of biblical drama House of David. The series, which launched with three episodes on February 27, drew 22 ...

By Rick Porter Television Writer The Amazon-owned streamer has renewed House of David for a second season. The pickup for the biblical drama comes a couple weeks before the show’s first season ...

During part one of the reunion show, which aired on March 11, David and Madison confirmed they are still together one year after the show wrapped filming. They also announced that they are living ...

AstraZeneca will leverage Alteogen’s platform technology to develop the therapies. Credit: © AstraZeneca 2025. AstraZeneca has entered an exclusive licence ...

Image credit: Kateryna Kon / Shutterstock. UK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic hypoparathyroidism. The Calypso ...

Monday was a busy day for AstraZeneca, which also paid up to $1 billion to acquire Belgian biotech EsoBiotec and its cell therapy pipeline and technology. AstraZeneca capped off a hectic Monday with a ...